Catalyst Capital Advisors LLC Takes Position in Express Scripts Holding (ESRX)

Catalyst Capital Advisors LLC purchased a new stake in shares of Express Scripts Holding (NASDAQ:ESRX) during the 4th quarter, Holdings Channel reports. The fund purchased 4,700 shares of the company’s stock, valued at approximately $351,000.

Several other institutional investors also recently made changes to their positions in the stock. Ameriprise Financial Inc. lifted its position in shares of Express Scripts by 23.5% in the 3rd quarter. Ameriprise Financial Inc. now owns 5,233,327 shares of the company’s stock worth $331,374,000 after purchasing an additional 996,816 shares during the period. Pzena Investment Management LLC increased its stake in Express Scripts by 23.6% during the 3rd quarter. Pzena Investment Management LLC now owns 3,509,800 shares of the company’s stock valued at $222,241,000 after purchasing an additional 670,922 shares in the last quarter. Schwab Charles Investment Management Inc. increased its stake in Express Scripts by 21.1% during the 3rd quarter. Schwab Charles Investment Management Inc. now owns 3,700,527 shares of the company’s stock valued at $234,318,000 after purchasing an additional 644,208 shares in the last quarter. Koch Industries Inc. grew its stake in shares of Express Scripts by 13,567.7% in the 2nd quarter. Koch Industries Inc. now owns 537,004 shares of the company’s stock worth $529,000 after acquiring an additional 533,075 shares in the last quarter. Finally, Stifel Financial Corp grew its stake in shares of Express Scripts by 3,089.1% in the 3rd quarter. Stifel Financial Corp now owns 543,588 shares of the company’s stock worth $34,402,000 after acquiring an additional 526,543 shares in the last quarter. 87.46% of the stock is currently owned by institutional investors.

Several analysts have recently issued reports on ESRX shares. Robert W. Baird upped their target price on shares of Express Scripts from $57.00 to $59.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 25th. Zacks Investment Research downgraded shares of Express Scripts from a “buy” rating to a “sell” rating in a report on Tuesday, October 24th. Royal Bank of Canada set a $66.00 price target on shares of Express Scripts and gave the stock a “hold” rating in a report on Wednesday, October 25th. TheStreet raised shares of Express Scripts from a “c+” rating to a “b-” rating in a report on Monday, December 4th. Finally, Jefferies Group set a $80.00 price target on shares of Express Scripts and gave the stock a “buy” rating in a report on Friday, December 15th. Five equities research analysts have rated the stock with a sell rating, eight have given a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Hold” and an average price target of $79.29.

In other news, VP Glen D. Stettin sold 3,449 shares of the stock in a transaction that occurred on Thursday, January 11th. The stock was sold at an average price of $81.00, for a total transaction of $279,369.00. Following the completion of the sale, the vice president now owns 33,715 shares of the company’s stock, valued at $2,730,915. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Christine Houston sold 10,104 shares of the stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $70.08, for a total value of $708,088.32. Following the sale, the vice president now directly owns 87,400 shares of the company’s stock, valued at approximately $6,124,992. The disclosure for this sale can be found here. In the last three months, insiders have sold 17,001 shares of company stock valued at $1,249,505. Insiders own 0.68% of the company’s stock.

Shares of Express Scripts Holding (NASDAQ:ESRX) opened at $74.93 on Thursday. The firm has a market capitalization of $41,679.39, a P/E ratio of 10.76, a PEG ratio of 0.79 and a beta of 0.93. Express Scripts Holding has a 52 week low of $55.80 and a 52 week high of $83.49. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73.

Express Scripts announced that its board has authorized a share repurchase plan on Monday, December 18th that authorizes the company to buyback 45,000,000 shares. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Shares buyback plans are usually an indication that the company’s board believes its stock is undervalued.

WARNING: This piece of content was originally published by Markets Daily and is the property of of Markets Daily. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this piece of content can be viewed at https://www.themarketsdaily.com/2018/02/15/catalyst-capital-advisors-llc-takes-position-in-express-scripts-holding-esrx.html.

About Express Scripts

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply